With an average of 21 years of industry experience and knowledge across all therapeutic areas.
Meet the Leadership Team

Yvonne also spent time in the biotech world as Clinical Development Manager then moved into senior Contract Research Organisation (CRO) roles.
With 25+ years of clinical trial experience gained across most therapeutic areas, Yvonne brings a deep understanding of all phases of the drug development process. With a passion for exceeding client expectations, Yvonne is highly regarded within the industry for her expertise and ability to solve complex clinical trial issues.
In 2009 Yvonne Lungershausen became a Founding Member of CPR Pharma Services (CPR) as it spun out from the University of South Australia. As a key member of the CPR Senior Management Team she was responsible for the clinical operations side of the business.
Then in January 2019 CPR Pharma Services split into two separate service companies, analytical services (Agilex BioLabs) and clinical services (Avance Clinical).
Yvonne was appointed as CEO of Avance Clinical and has since rapidly built the company into Australia’s leading CRO for biotechs – attracting innovative biotech clients from USA, EU and Asia and winning awards for quality and service.

He has been part of the CPR Pharma Services team since 2015 managing the department of clinical operations and offering drug development advice to biotechnology companies seeking to enter clinical trials in Australia. In 2019, Gabriel was appointed Chief Scientific Officer of Avance Clinical where he currently leads the Department of Scientific and Medical affairs offering Medical Writing, Drug safety monitoring and reporting and early phase clinical drug development and regulatory advice services.
Prior to joining CPR Pharma Services, Gabriel was the Vice President Research & Development of the Australian ASX listed company Bionomics limited where over several years led teams in discovery and progression of cancer therapeutics through to completion of several phase I and Phase II clinical trials in Australia and the US.
Gabriel’s 26 years in medical research also includes appointments with the Cancer Therapeutics CRC, Flinders University of South Australia, Adelaide University, the Los Alamos National Laboratories and the Adelaide Women’s and Children’s Hospital.
With primary expertise in oncology, Gabriel has a diverse scientific background spanning the fields of Clinical Development, Drug Discovery, Cancer Biology, Molecular Genetics, Bioinformatics and Immunology. He has a PhD and a Bachelor of Science (Honours) from Flinders University and a Bachelor of Science from The University of Melbourne. He has published research findings in 29 international scientific papers and has several patent inventions on cancer genes and small molecule anti-cancer therapeutics. Gabriel is a member of the American Association for Cancer Research, the American Society of Clinical Oncology and ARCS Australia.

As an accomplished leader of teams with significant experience in directing large multi-function teams across all continents Ben values an action oriented work ethic, high ethical standards, personal integrity and accountability as well as the power of a ‘team first’ culture. These values have been the guiding force for delivering value to clients and ensuring patients get the treatment they need.

Jemma brings to Avance Clinical in-depth experience in Clinical Operations supported by 17+ years’ experience working in the clinical research and biotechnology industries, including 12+ years dedicated to various roles in Contract Research Organisations (CROs). Her comprehensive knowledge draws from working with both small Australian-based CROs and large multinational (including Top 5) CROs, with a particular focus on early phase Healthy Volunteer and Oncology clinical development.
Highly developed people management expertise, demonstrated accountability for a project delivery, thorough clinical project financial management experience, and an innate love for process improvement and development/implementation, provide her with a solid foundation to deliver on the continued growth and development of the Avance Clinical Operations department.

Sandrien has significant experience in senior managerial roles, currently serving as Director Business Development Operations supporting clients across the United States.


Greg is a hands-on, results-oriented executive that loves the dynamics and challenges of innovative and fast-growing companies. His philosophy of being an effective CFO is about partnering with his colleagues and providing the tools, information and analysis that empower each of them to drive exceptional performance. A commercially focused, results driven finance leader with experience in building and leading diverse teams across the globe.



Priyanka has worked in Pharma, Multinational and small to mid-sized CROs during her career.
She has extensive experience auditing Investigator sites and vendors across multiple regions including Asia, Africa, Australia, Europe and the USA covering many therapeutic areas.
At Avance Clinical Priyanka is responsible for quality systems and auditing for Clinical Operations, Data Management, Medical Writing and Statistics.


Meet the Client Development Team
A highly experienced business development team supporting our global clients.


Worked across a variety of positions in clinical trial coordination, project management, laboratory management, SOP writing/review, business development, clinical trial budgets and proposals, contract drafting and key client negotiations, legal counsel liaison, implementation of new systems and supporting the growth of a small start-up company of 3 employees as a foundation employee, to an SME of over 250 employees.
I enjoy working with a team open to big ideas and finding new and innovative ways to improve processes and workflows, but my favourite part is watching my teammates grow and flourish in their roles, seeing that “aha!” moment and knowing that I had a small part to play in guiding their success.

Prior to that George joined C3 Research in 2017. He has over 20 years of transaction experience, of which over a decade has been devoted to the practice of business development and clinical operations within the clinical development industry. Since joining industry, he has held executive leadership responsibilities across early and late phase CRO providers. Since joining the C3 Research team, George has played an instrumental role in contributing to the growth of the company. He brings with him a unique vision that places the individual needs of every client, central to all the division’s business practices. His day-to-day contributions are grounded in a simple yet profound idea — good and proper business development lends itself to a strong foundation for dynamic and comprehensive solutions and a tailored approach to meeting biotech and pharmaceutical development challenges.


Sandrien has significant experience in senior managerial roles, currently serving as Director Business Development Operations supporting clients across the United States.

“Clients select Avance Clinical in Australia because the data is accepted by the FDA, and it gives them a rapid pathway for international licensing, investment and ultimately drug approvals.”

Meet the Board
A highly experienced business and investor team




